skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.08d (Release date: 2017-08-28)
SearchBox Top
SearchBox Bottom
Recombinant Leukocyte Interleukin (Code C2413)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Recombinant Leukocyte Interleukin

Definition: A cocktail preparation of synthetic interleukin (IL) -1, IL-2, IL-6, tumor necrosis factor (TNF)-alpha, interferon gamma and other cytokines that are chemically identical to or similar to signaling molecules secreted by leukocyte cells. Leukocyte interleukins are essential in many immune responses, such as antibodies production, modulating secretion of other cytokines, and activation of bone marrow stem cells.

Label: Recombinant Leukocyte Interleukin

NCI Thesaurus Code: C2413 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C0392999  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Buffy Coat Interleukin
Leukocyte Interleukin, Inj.
Recombinant Leukocyte Interleukin

External Source Codes: 
PDQ Closed Trial Search ID 42580
PDQ Open Trial Search ID 42580 (check for NCI PDQ open clinical trial info)
UMLS CUI C0392999

Other Properties:
     Name Value (qualifiers indented underneath)
Accepted_Therapeutic_Use_For neoadjuvant therapy for patients with squamous cell carcinoma of the head and neck
code C2413
Legacy_Concept_Name Therapeutic_Leukocyte_Interleukin
Semantic_Type Amino Acid, Peptide, or Protein
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom